Silverfin false false 31/10/2024 01/11/2023 31/10/2024 Dr S Karpati 25/10/2023 Dr J Mayer 25/10/2023 14 March 2025 The principal activity of the company is the provision of healthcare consultancy 15235341 2024-10-31 15235341 bus:Director1 2024-10-31 15235341 bus:Director2 2024-10-31 15235341 core:CurrentFinancialInstruments 2024-10-31 15235341 core:ShareCapital 2024-10-31 15235341 core:RetainedEarningsAccumulatedLosses 2024-10-31 15235341 core:OtherPropertyPlantEquipment 2023-10-31 15235341 2023-10-31 15235341 core:OtherPropertyPlantEquipment 2024-10-31 15235341 bus:OrdinaryShareClass1 2024-10-31 15235341 bus:OrdinaryShareClass2 2024-10-31 15235341 bus:OrdinaryShareClass3 2024-10-31 15235341 bus:OrdinaryShareClass4 2024-10-31 15235341 2023-11-01 2024-10-31 15235341 bus:FilletedAccounts 2023-11-01 2024-10-31 15235341 bus:SmallEntities 2023-11-01 2024-10-31 15235341 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 15235341 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 15235341 bus:Director1 2023-11-01 2024-10-31 15235341 bus:Director2 2023-11-01 2024-10-31 15235341 core:OtherPropertyPlantEquipment core:TopRangeValue 2023-11-01 2024-10-31 15235341 core:OtherPropertyPlantEquipment 2023-11-01 2024-10-31 15235341 bus:OrdinaryShareClass1 2023-11-01 2024-10-31 15235341 bus:OrdinaryShareClass2 2023-11-01 2024-10-31 15235341 bus:OrdinaryShareClass3 2023-11-01 2024-10-31 15235341 bus:OrdinaryShareClass4 2023-11-01 2024-10-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 15235341 (England and Wales)

S&J MEDICAL LIMITED

Unaudited Financial Statements
For the financial year ended 31 October 2024
Pages for filing with the registrar

S&J MEDICAL LIMITED

Unaudited Financial Statements

For the financial year ended 31 October 2024

Contents

S&J MEDICAL LIMITED

BALANCE SHEET

As at 31 October 2024
S&J MEDICAL LIMITED

BALANCE SHEET (continued)

As at 31 October 2024
Note 2024
£
Fixed assets
Tangible assets 3 628
628
Current assets
Cash at bank and in hand 15,123
15,123
Creditors: amounts falling due within one year 4 ( 4,944)
Net current assets 10,179
Total assets less current liabilities 10,807
Net assets 10,807
Capital and reserves
Called-up share capital 5 100
Profit and loss account 10,707
Total shareholders' funds 10,807

For the financial year ending 31 October 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of S&J Medical Limited (registered number: 15235341) were approved and authorised for issue by the Board of Directors on 14 March 2025. They were signed on its behalf by:

Dr S Karpati
Director
S&J MEDICAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 October 2024
S&J MEDICAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 October 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year, unless otherwise stated.

General information and basis of accounting

S&J Medical Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Lowin House, Tregolls Road, Truro, TR1 2NA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Taxation

Current Tax

Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a [straight-line, reducing balance] basis over its expected useful life, as follows:

Plant and machinery etc. 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

2. Employees

2024
Number
Monthly average number of persons employed by the Company during the year, including directors 0

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 November 2023 0 0
Additions 628 628
At 31 October 2024 628 628
Accumulated depreciation
At 01 November 2023 0 0
At 31 October 2024 0 0
Net book value
At 31 October 2024 628 628

4. Creditors: amounts falling due within one year

2024
£
Taxation and social security 2,364
Other creditors 2,580
4,944

5. Called-up share capital

2024
£
Allotted, called-up and fully-paid
30 A ordinary shares of £ 1.00 each 30
30 B ordinary shares of £ 1.00 each 30
20 C ordinary shares of £ 1.00 each 20
20 D ordinary shares of £ 1.00 each 20
100